Shares of Gilead Sciences Inc. GILD, +1.28% slid 1.04% to $61.81 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX, +1.92% falling 0.30% to 3,790.38 and Dow Jones Industrial Average DJIA, +2.15% falling 0.46% to 30,630.17. Gilead Sciences Inc. closed $12.31 short of its 52-week high ($74.12), which the company achieved on December 30th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson JNJ, +1.45% rose 0.14% to $175.68, Merck & Co. Inc. MRK, +1.15% rose 0.12% to $93.88, and AbbVie Inc. ABBV, +2.11% fell 0.20% to $150.44. Trading volume (5.0 M) remained 2.7 million below its 50-day average volume of 7.7 M.